Ardelyx (ARDX) Research & Development (2013 - 2026)

Ardelyx (ARDX) reported Research & Development of $20.2 million for Q1 2026, up 35.15% on a YoY basis from $14.9 million in Q1 2025, and down 11.67% quarter-over-quarter from $22.9 million in Q4 2025.

Ardelyx (ARDX) Research & Development (2013 - 2026) Analysis & Trends

Ardelyx has reported Research & Development for 14 years, with the latest figure at $20.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development rose 35.15% year-over-year to $20.2 million; the trailing twelve-month figure through Mar 2026 stood at $76.8 million (up 35.47% YoY), and the FY2025 full-year result was $71.5 million, up 36.72% from the prior year.
  • Research & Development for Q1 2026 stood at $20.2 million, down from $22.9 million in the prior quarter.
  • The five-year high for Research & Development was $22.9 million in Q4 2025, with the low at $7.5 million in Q3 2022.
  • Historically, Research & Development has averaged $12.6 million across 5 years, with a median of $10.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Research & Development plunged 68.49% — and 2024, when it surged 77.26%.
  • Ardelyx's Research & Development stood at $9.1 million in 2022, then rose by 4.18% to $9.5 million in 2023, then soared by 43.49% to $13.7 million in 2024, then jumped by 67.25% to $22.9 million in 2025, then declined by 11.67% to $20.2 million in 2026.
  • The last three Research & Development figures came in at $20.2 million (Q1 2026), $22.9 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 20.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.19 Mn
Dec 31, 2025 22.86 Mn
Sep 30, 2025 18.07 Mn
Jun 30, 2025 15.67 Mn
Mar 31, 2025 14.94 Mn
Dec 31, 2024 13.67 Mn
Sep 30, 2024 15.31 Mn
Jun 30, 2024 12.76 Mn
Mar 31, 2024 10.58 Mn
Dec 31, 2023 9.52 Mn
Sep 30, 2023 8.64 Mn
Jun 30, 2023 8.28 Mn
Mar 31, 2023 9.09 Mn
Dec 31, 2022 9.14 Mn
Sep 30, 2022 7.47 Mn
Jun 30, 2022 9.74 Mn
Mar 31, 2022 8.85 Mn
Dec 31, 2021 20.97 Mn
Sep 30, 2021 23.70 Mn
Jun 30, 2021 26.02 Mn